Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91 publications
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies.
Journal: Blood
Published: September 02, 2025
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies.
Journal: Blood
Published: September 02, 2025
The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM.
Journal: Cell
Published: July 28, 2025
Classification of patients with relapsed/refractory large B-cell lymphoma who do not develop early CRS/NE toxicity using ZUMA clinical trial data.
Journal: Journal for immunotherapy of cancer
Published: July 11, 2025
Author Correction: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial.
Journal: Nature medicine
Published: June 11, 2025
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies.
Journal: Nature communications
Published: February 16, 2025
D3-GPC2-Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 09, 2025
IL-6 Blockade in Cytokine Storm Syndromes.
Journal: Advances in experimental medicine and biology
Published: August 08, 2024
CD5 deletion enhances the antitumor activity of adoptive T cell therapies.
Journal: Science immunology
Published: July 19, 2024
Building smart CAR T cell therapies: The path to overcome current challenges.
Journal: Cancer cell
Published: August 22, 2023
Last Updated: 09/26/2026